RYTM earnings
Rhythm Pharmaceuticals (RYTM) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
RYTM earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 4, 2026 | -0.73 | -0.81 | 9.57% | $71.25M |
| Q1 2026 | May 5, 2026 | -0.83 | -0.86 | 3.49% | $60.11M |
| Q4 2025 | Feb 26, 2026 | -0.73 | -0.79 | 7.59% | $57.25M |
| Q3 2025 | Nov 4, 2025 | -0.82 | -0.72 | -13.89% | $51.30M |
| Q2 2025 | Aug 5, 2025 | -0.75 | -0.66 | -13.64% | $48.50M |
| Q1 2025 | May 7, 2025 | -0.81 | -0.69 | -17.39% | $32.70M |
| Q4 2024 | Feb 26, 2025 | -0.72 | -0.69 | -4.35% | $41.83M |
| Q3 2024 | Nov 5, 2024 | -0.73 | -0.80 | 8.75% | $33.25M |
| Q2 2024 | Aug 6, 2024 | -0.55 | -0.70 | 21.43% | $29.08M |
| Q1 2024 | May 7, 2024 | -2.35 | -2.34 | -0.43% | $25.97M |
| Q4 2023 | Feb 22, 2024 | -0.70 | -0.70 | 0.00% | $24.23M |
| Q3 2023 | Nov 7, 2023 | -0.76 | -0.76 | 0.00% | $22.50M |
| Aug 1, 2023 | -0.82 | -0.80 | -2.50% | – | |
| May 2, 2023 | -0.92 | -0.71 | -29.58% | – | |
| Mar 1, 2023 | -0.75 | -0.82 | 8.54% | – | |
| Nov 8, 2022 | -0.79 | -1.01 | 21.78% | – | |
| Aug 2, 2022 | -0.89 | -0.79 | -12.66% | – | |
| May 3, 2022 | -1.05 | -0.98 | -7.14% | – | |
| Mar 1, 2022 | -0.85 | -1.00 | 15.00% | – | |
| Nov 2, 2021 | -0.70 | -0.84 | 16.67% | – |
- RYTM reports next on Nov 3, 2026, with EPS of -0.72 expected.
- RYTM beat EPS estimates in 20 of its last 36 reports.
Updated 2026-11-03 00:01 UTC